May 27, 2015 — Mid Atlantic Bio Angels (MABA) announced that Ultravision LLC was chosen as "Best in Show" at MABA's New Jersey 1st Pitch Life Science event. The event took place at the Institute for Life Science Entrepreneurship on the campus of Kean University in Union, New Jersey, on May 6, 2015. Ultravision is a medical device company that has developed a unique ultrasound needle that allows physicians to perform peripheral nerve blocks for pain management while using color to identify their location.
Physicians are increasingly using ultrasound to identify appropriate locations to perform peripheral nerve blocks for pain control. Patients who have recently undergone surgery or experienced an injury often have lower stress hormone levels when these blocks are performed. Physicians using currently available ultrasound devices only see these images for nerve blocks in black and white. In contrast Ultravision's color technology allows more accurate placement and better localization of the block needle.
"With a good business partner, Dr. [Allen] Maizes' [Ultravision CEO] clever approach to improving echnogenic nerve block needles has a good shot at becoming a product that will reduce complications, save anesthesiologists' time and make some good money," said Bruce Toman, 1st Pitch steering committee member, technology licensing officer at Cornell University and panel member at the event.
For more information: www.1stpitchlifescience.com